Company to showcase CorynexTM Recombinant Protein Expression System
Ajinomoto North America, Inc., Amino Acid Technologies today announced it is exhibiting at PepTalk, January 9-13, 2012, in San Diego, CA. Ajinomoto executives will be on hand at booth #22 giving out copies of its "Speeding and Simplifying Recombinant Protein Production" whitepaper and related case studies, as well as showcasing the its animated protein expression video.
Attendees are encouraged to stop by booth #22 to receive their own copy of the whitepaper, which outlines common challenges associated with recombinant protein production and discusses how novel expression systems, such as the CorynexTMRecombinant Protein Expression System, are helping simplify the production process, reduce costs, and speed time to market. Two case studies describing how Ajinomoto customers have used Corynex to viably express difficult proteins are also available.
In addition to the whitepaper and case studies, Ajinomoto will have on display its educational video that uses computer-generated animation to illustrate protein expression in a way that's never before been seen. The video provides an in-depth look at the expression and export of recombinant proteins from Corynebacterium glutamicum compared to E. coli and demonstrates how CorynexTM allows the recombinant protein to be readily purified directly from the fermentation broth.
If you are not attending PepTalk, you can still download free copies of the whitepaper and case studies, and view the animation of Ajinomoto's CorynexTM Recombinant Protein Expression System at www.corynex.com.
The 11th annual PepTalk eventis comprised of four distinct protein pipelines focused on formulation, purification, biotherapeutics and expression range from applying protein discovery research, to developing downstream protein products that ultimately lead to clinical applications. Additional networking opportunities will be available through BuzZ Session discussion groups, short courses and panel discussions.
About Ajinomoto North America, Inc., Amino Acid Technologies
Ajinomoto is the leading global supplier of pharmaceutical and research-grade amino acids. Leveraging its unrivaled foundation of more than 50 years experience identifying, refining, and marketing amino acids, Amino Acid Technologies continues to innovate and set new industry standards for manufacturing and related services within the fermentation and expression fields. Building on its legacy, Amino Acid Technologies has transitioned the same level of quality and performance into new core competencies in the areas of recombinant protein expression and peptide synthesis. These new processes enable pharmaceutical and biotech companies to develop high-quality products that were previously thought to be too complicated or expensive to produce. The CorynexTMRecombinant Protein Expression System is a streamlined, more efficient process to produce complex human proteins for pharmaceutical use using a specially-developed gram-positive bacterium, Corynebacterium glutamicum. The AjiPhase™ service enables the use of a single peptide synthesis methodology throughout therapeutic peptide development as peptide requirements increase. Amino Acid Technologies is a part of Ajinomoto North America, Inc., a wholly-owned subsidiary of Ajinomoto Co., Inc. For more information, please refer to http://www.ajiaminoscience.com/Default.aspx##.
Contacts:
Crossroads Public Relations for Ajinomoto Amino Acid Technologies
Molly
Thompson
aji@crossroadspr.com
919-605-0022
(m)
919-821-2822 (o)
